Association between multiple sclerosis and Candida species: evidence from a case-control study.

Area of Science:

• Immunology
• Infectious Diseases
• Neurology

Background:

• Multiple sclerosis (MS) is a chronic neurological disease with complex etiology.
• The role of fungal infections, specifically Candida species, in MS pathogenesis remains under-investigated.

Purpose of the Study:

• To investigate the potential association between serological evidence of Candida infection and the presence of multiple sclerosis.
• To determine if Candida species antibodies or antigens correlate with MS diagnosis.

Main Methods:

• Blood samples were collected from 80 MS patients and 240 matched controls.
• Immunofluorescence analysis and ELISA were used to detect Candida antibodies.
• Slot-blot assays identified Candida antigens in patient and control samples.

Main Results:

• MS patients showed significantly higher concentrations of antibodies to Candida famata, Candida albicans, Candida parapsilosis, and Candida glabrata compared to controls (p < 0.001 for all).
• The presence of Candida parapsilosis and Candida glabrata antigens was significantly associated with increased odds of MS (OR 7.3, p < 0.001 and OR 3.0, p = 0.002, respectively).
• These associations remained significant even after adjusting for age, gender, and excluding patients on immunosuppressants.

Conclusions:

• Serological evidence of Candida species infection is significantly more prevalent in multiple sclerosis patients.
• Candida parapsilosis and Candida glabrata infections may be linked to an increased risk of developing multiple sclerosis.
• Further research is warranted to elucidate the causal relationship between Candida infections and MS.